Screener / SEC EDGAR /CIK 0000874015 /10-K filed Feb 26, 2026, compared with Feb 19, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Health care · Pharmaceuticals

Ionis Pharmaceuticals Inc IONS

Compare with peers Embed
Planned sales, announced before they happen

10 trading plans running, 63 Form 144 notices for $144.7M

10-Q, 10-K and Form 144
Plans running now 10 Frank Bennett, Holly Kordasiewicz, Elizabeth Hougen, Joseph Wender, Brett Monia, Kyle Jenne, Joseph Klein, Eugene Schneider, Joseph Loscalzo
Plans adopted 32 reported since May 3, 2023 Form 144 notices 63 $144.7M the sellers expected to sell

What IONS's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.

Plans adopted or ended

Trading plans · XBRL, 10-Q and 10-K

From Nov 19, 2025 to Sep 30, 2028. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired. The ten newest plans are drawn; all are in the table.

InsiderWhatDateReported in
Shannon Devers
Executive Vice President, Chief Human Resources Officer
Ended 10b5-1 plan Apr 14, 2026 10-Q Jul 29, 2026
Frank Bennett
Executive Vice President, Chief Scientific Officer
Adopted 10b5-1 plan Mar 31, 2026 10-Q Apr 29, 2026
Holly Kordasiewicz
Executive Vice President, Chief Development Officer
Adopted 10b5-1 plan Mar 13, 2026 10-Q Apr 29, 2026
Eric Swayze
Executive Vice President, Research
Ended 10b5-1 plan Mar 6, 2026 10-Q Apr 29, 2026
Elizabeth Hougen
Executive Vice President, Finance and Chief Financial Officer
Adopted 10b5-1 plan Dec 9, 2025 10-K Feb 26, 2026
Joseph Wender
Board Member
Adopted 10b5-1 plan Dec 9, 2025 10-K Feb 26, 2026
Brett Monia
Chief Executive Officer
Adopted 10b5-1 plan Dec 8, 2025 10-K Feb 26, 2026
Kyle Jenne
Executive Vice President, Chief Global Product Strategy Officer
Adopted 10b5-1 plan Dec 8, 2025 10-K Feb 26, 2026
Patrick O'Neil
Executive Vice President, Chief Legal Officer and General Counsel
Ended 10b5-1 plan Dec 8, 2025 10-K Feb 26, 2026
Joseph Klein
Board Member
Adopted 10b5-1 plan Nov 25, 2025 10-K Feb 26, 2026
Shannon Devers
Executive Vice President, Chief Human Resources Officer
Adopted 10b5-1 plan Nov 24, 2025 10-K Feb 26, 2026
Joseph Baroldi
Executive Vice President, Chief Business Officer
Ended 10b5-1 plan Nov 23, 2025 10-K Feb 26, 2026
Eugene Schneider
Executive Vice President, Chief Clinical Development and Operations Officer
Adopted 10b5-1 plan Nov 19, 2025 10-K Feb 26, 2026
Frank Bennett
Executive Vice President, Chief Scientific Officer
Adopted 10b5-1 plan Nov 19, 2025 10-K Feb 26, 2026
Joseph Loscalzo
Board Member
Adopted 10b5-1 plan Nov 18, 2025 10-K Feb 26, 2026
Allene Diaz
Board Member
Ended 10b5-1 plan Nov 17, 2025 10-K Feb 26, 2026
B. Lynne Parshall
Board Member
Adopted 10b5-1 plan May 6, 2025 10-Q Jul 30, 2025
Frank Bennett
Chief Scientific Officer
Ended 10b5-1 plan May 6, 2025 10-Q Jul 30, 2025
Richard Geary
Chief Development Officer
Adopted 10b5-1 plan May 6, 2025 10-Q Jul 30, 2025
Eugene Schneider
Chief Clinical Development and Operations Officer
Adopted 10b5-1 plan May 2, 2025 10-Q Jul 30, 2025
Joseph Baroldi
Chief Business Officer
Adopted 10b5-1 plan May 2, 2025 10-Q Jul 30, 2025
Patrick O' Neil
Chief Legal Officer and General Counsel
Adopted 10b5-1 plan May 2, 2025 10-Q Jul 30, 2025
Spencer Berthelsen
Director
Adopted 10b5-1 plan Sep 11, 2024 10-Q Nov 6, 2024
Shannon L. Devers
EVP, Chief Human Resources Officer
Adopted 10b5-1 plan Sep 3, 2024 10-Q Nov 6, 2024
Brett P. Monia
Chief Executive Officer
Adopted 10b5-1 plan Aug 12, 2024 10-Q Nov 6, 2024
Brian Birchler
EVP, Corporate and Development Operations
Adopted 10b5-1 plan Aug 12, 2024 10-Q Nov 6, 2024
C. Frank Bennett
EVP, Chief Scientific Officer
Adopted 10b5-1 plan Aug 12, 2024 10-Q Nov 6, 2024
Eric Swayze
EVP, Research
Ended 10b5-1 plan Aug 12, 2024 10-Q Nov 6, 2024
Joseph Loscalzo
Board Member
Adopted 10b5-1 plan Aug 12, 2024 10-Q Nov 6, 2024
Brett P. Monia
Chief Executive Officer
Ended 10b5-1 plan Jun 26, 2024 10-Q Aug 1, 2024
Richard S. Geary
EVP, Chief Development Officer
Adopted 10b5-1 plan Apr 8, 2024 10-Q Aug 1, 2024
Patrick O'Neil
Chief Legal Officer & General Counsel
Ended 10b5-1 plan Feb 14, 2024 10-Q May 7, 2024
Elizabeth Hougen
EVP, Finance & Chief Financial Officer
Adopted 10b5-1 plan Jan 12, 2024 10-Q May 7, 2024
Eugene Schneider
EVP, Chief Clinical Development and Operations Officer
Adopted 10b5-1 plan Jan 12, 2024 10-Q May 7, 2024
Joseph Baroldi
EVP, Chief Business Officer
Adopted 10b5-1 plan Jan 5, 2024 10-Q May 7, 2024
B. Lynne Parshall
Board Member
Ended 10b5-1 plan Jan 3, 2024 10-Q May 7, 2024
Joseph Klein, III
Board Member
Adopted 10b5-1 plan Jan 3, 2024 10-Q May 7, 2024
B. Lynne Parshall
Board Member
Adopted 10b5-1 plan Sep 27, 2023 10-Q Nov 2, 2023
Spencer Berthelsen
Board Member
Adopted 10b5-1 plan Sep 7, 2023 10-Q Nov 2, 2023
Eric Swayze
EVP, Research
Adopted 10b5-1 plan Jul 13, 2023 10-Q Nov 2, 2023
Brett Monia
CEO and Board Member
Ended 10b5-1 plan Jul 12, 2023 10-Q Nov 2, 2023
C. Frank Bennett
EVP, Chief Scientific Officer
Adopted 10b5-1 plan Jun 29, 2023 10-Q Aug 9, 2023
Eric Swayze
EVP, Research
Ended 10b5-1 plan Jun 28, 2023 10-Q Aug 9, 2023
Allene Diaz
Board Member
Adopted 10b5-1 plan May 3, 2023 10-Q Aug 9, 2023
Show the other 36 plans

From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 3, 2023.

Notices of planned sales

Form 144 · Form 144 XML, SEC

What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).

FiledSellerSharesValue
Oct 16, 2026 Devers Shannon L.
Officer
1,357 $60K
Jul 7, 2026 Diaz Allene M.
Director
10,111 $864K
Jul 7, 2026 Kordasiewicz Holly B.
Officer
1,287 $108K
Jul 7, 2026 BENNETT C FRANK
Officer
67,386 $5.7M
Jul 1, 2026 KLEIN JOSEPH III
Director
11,518 $910K
Jun 26, 2026 Baroldi Mariana
Member of immediate family of any of the foregoing
5,635 $452K
Jun 26, 2026 O'NEIL PATRICK R.
Officer
3,069 $246K
Jun 26, 2026 Schneider Eugene
Officer
47,884 $3.9M
Jun 25, 2026 Swayze Eric
Officer
10,602 $839K
Jun 15, 2026 BERTHELSEN SPENCER R
Director
8,000 $588K
Jun 12, 2026 Kordasiewicz Holly B.
Officer
60,846 $4.5M
Jun 1, 2026 BERTHELSEN SPENCER R
Director
8,000 $605K
May 13, 2026 Monia Brett P
Officer
100,000 $7.8M
May 4, 2026 LOSCALZO JOSEPH
Director
54,321 $4.3M
Apr 28, 2026 Baroldi Joseph
Officer
1,626 $117K
Apr 16, 2026 Jenne Kyle
Officer
4,902 $370K
Apr 16, 2026 Birchler Brian
Officer
973 $73K
Apr 16, 2026 Baroldi Joseph
Officer
5,619 $424K
Mar 31, 2026 Diaz Allene M.
Director
68,800 $5.5M
Mar 24, 2026 Schneider Eugene
Officer
5,812 $412K
Mar 19, 2026 Schneider Eugene
Officer
5,812 $412K
Mar 16, 2026 HOUGEN ELIZABETH L
Officer
225,200 $16.3M
Mar 10, 2026 Jenne Kyle
Director
58,253 $4.4M
Mar 9, 2026 O'NEIL PATRICK R.
Officer
13,217 $995K
Mar 3, 2026 BENNETT C FRANK
Officer
85,089 $7.1M
Mar 3, 2026 LOSCALZO JOSEPH
Director
24,000 $1.9M
Mar 3, 2026 Baroldi Mariana
Officer
8,198 $656K
Mar 3, 2026 Baroldi Joseph
Officer
4,096 $325K
Mar 3, 2026 KLEIN JOSEPH III
Director
65,345 $5.0M
Mar 3, 2026 Devers Shannon L.
Officer
39,014 $3.1M
Feb 13, 2026 Swayze Eric
Officer
15,642 $1.3M
Feb 11, 2026 PARSHALL B LYNNE
Director
10,000 $827K
Feb 6, 2026 Monia Brett P
Officer
290,203 $24.8M
Feb 2, 2026 BENNETT C FRANK
Officer
85,089 $7.1M
Jan 30, 2026 Baroldi Joseph
Officer
5,296 $440K
Jan 30, 2026 Birchler Brian
Officer
6,179 $512K
Jan 30, 2026 BENNETT C FRANK
Officer
5,885 $488K
Jan 30, 2026 HOUGEN ELIZABETH L
Officer
6,988 $580K
Jan 30, 2026 Monia Brett P
Officer, Director
62,970 $5.2M
Jan 30, 2026 O'NEIL PATRICK R.
Officer
6,179 $513K
Jan 30, 2026 Swayze Eric
Officer
6,179 $513K
Jan 30, 2026 Schneider Eugene
Officer
6,179 $513K
Jan 23, 2026 Devers Shannon L.
Officer
3,977 $323K
Jan 22, 2026 Devers Shannon L.
Officer
3,977 $323K
Jan 21, 2026 Baroldi Mariana
Member of immediate family of any of the foregoing
1,171 $94K
Jan 16, 2026 Swayze Eric
Officer
9,884 $754K
Jan 16, 2026 Baroldi Joseph
Officer
6,999 $560K
Jan 16, 2026 BENNETT C FRANK
Officer
8,977 $684K
Jan 16, 2026 Birchler Brian
Officer
8,480 $646K
Jan 16, 2026 HOUGEN ELIZABETH L
Officer
12,922 $985K
Jan 16, 2026 Monia Brett P
Officer, Director
44,034 $3.4M
Jan 16, 2026 Kordasiewicz Holly B.
Officer
4,141 $315K
Jan 16, 2026 O'NEIL PATRICK R.
Officer
9,191 $701K
Jan 16, 2026 Schneider Eugene
Officer
9,302 $709K
Jan 16, 2026 Jenne Kyle
Officer
1,823 $139K
Jan 16, 2026 Devers Shannon L.
Officer
8,353 $637K
Jan 7, 2026 Devers Shannon L.
Officer
9,390 $795K
Jan 2, 2026 Swayze Eric
Officer
23,463 $1.6M
Dec 1, 2025 Joseph Wender
Director
33,600 $2.5M
Dec 1, 2025 Joseph Wender
Director
14,479 $1.2M
Nov 25, 2025 Devers Shannon L.
Officer
42,322 $3.4M
Nov 25, 2025 KLEIN JOSEPH III
Director
12,000 $960K
Nov 19, 2025 Joan E. Herman
Director
44,000 $3.3M
Show the other 55 notices

From the Form 144 XML filed with the SEC, since Nov 19, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.

Sources

Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.

Also

Insider trades: the Form 4s for the sales these plans led to.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/IONS/export.csv") into a cell.

Next:Owners
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.